| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | 0.093 | 0.002 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.089 | 0.003 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | 0.092 | 0.003 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | 0.17 | 0.003 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.089 | 0.003 |
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.089 | 0.003 |